title: Interleukin-1 receptor antagonist inhibits growth modulation of human tumor-cell lines by interleukin-1 in-vitro.
abstract: In this study we report that recombinant human (rh) interleukin-1alpha (IL-1alpha) has direct and dose-dependent growth-modulating effects on human tumor cell lines in vitro as measured by a human tumor cloning assay (HTCA). Colony formation of the melanoma cell line A 375 was inhibited by rhIL-1alpha, whereas colony formation of the glioblastoma cell line HTB 14 was enhanced by this cytokine. Both growth-modulating effects were dose-dependent, however with some saturation. Subsequently, we have tested the activity of recombinant human IL-1 receptor antagonist (rhIL-1ra) on the tumor growth modulation by rhIL-1alpha. Tumor cells were incubated with increasing concentrations of rhIL-1ra and then added to the cultures containing rHIL-1alpha. Concentrations of rhIL-1ra were chosen to achieve a range between 0.01 and 100 ng/ml which includes a 1000-fold molar excess over IL-1alpha. The receptor antagonist was able to block both the inhibition and the stimulation of clonal growth of the respective tumor cell line by rhIL-1alpha. Furthermore, there was a direct dose dependent relationship revealing higher IL-1 antagonism of rhIL-1ra at higher concentrations with maximum efficacy at 1000-molar excess concentrations over IL-1alpha. In addition, rhIL-1ra alone did not reveal major modulation of the growth of A 375, but significantly decreased colony formation of HTB 14. We conclude that rhIL-1ra can counteract modulation of clonal growth of human tumor cells by IL-1alpha in vitro. Since our report provides first evidence that the stimulation of clonal tumor cell growth by IL-1alpha can be blocked by rhIL-1ra, this member of the IL-1 cytokine network should be further studied as a possible candidate for experimental cancer treatment.
authors.affiliation: FREE UNIV BERLIN,KLINIKUM STEGLITZ,DEPT HEMATOL ONCOL,30 HINDENBURGDAMM,D-12200 BERLIN,GERMANY.
authors.forename: E
authors.initials: E
authors.lastname: Oelmann
authors.forename: M
authors.initials: M
authors.lastname: Topp
authors.forename: B
authors.initials: B
authors.lastname: Reufi
authors.forename: C
authors.initials: C
authors.lastname: Papadimitriou
authors.forename: M
authors.initials: M
authors.lastname: Koenigsmann
authors.forename: D
authors.initials: D
authors.lastname: Oberberg
authors.forename: E
authors.initials: E
authors.lastname: Thiel
authors.forename: W
authors.initials: W
authors.lastname: Berdel